SYS-CON MEDIA Authors: Mat Mathews, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

Concise Analysis of the Future Prospects of Global Personalized Medicine Market

DUBLIN, March 5, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/5pbz3g/future_prospects) have announced the addition of the "Concise Analysis of the Future Prospects of Global Personalized Medicine Market" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Over the years, the Global Personalized Medicine market has been witnessing the emergence of various tools and technologies from the reputed vendors. For instance, AssureRx Health Inc. launched GeneSightRx ADHD in May 2012, a personalized medicine test for the growing number of children and adults diagnosed with ADHD. Moreover, Bristol-Myers Squibb Co. collaborated with MMRF in December 2012 for advanced personalized medicine for multiple Myeloma.

Further, Alacris Theranostics GmbH entered into an agreement with GlaxoSmithKline plc in November 2012 to use ModCell system for early stage cancer research. Further, AltheaDx Inc. launched FLT3 Mutation Assay in October 2012. Agendia N.V. launched ColoPrint microarray-based 18-gene expression signature in June 2012 for predicting the risk of distant recurrence for stage II colon cancer patients. The European Medicines Agency approved Zelboraf, manufactured by F. Hoffmann-La Roche Ltd., in December 2011.

Key Topics Covered:

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology

5. Scope of the Report

6. Market Landscape

7. Geographical Segmentation

8. Key Leading Countries

9. Vendor Landscape

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Key Vendor Analysis

17. Other Reports in this Series

Companies Mentioned:

  • Abbott Laboratories
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Co.
  • Celgene Corp.
  • Daiichi Sankyo Co. Ltd.
  • Danaher Corp.
  • Eli Lilly and Co.
  • Evotec AG
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Ltd.
  • Genelex Corp.
  • GlaxoSmithKline plc
  • Hologic Inc.
  • Johnson & Johnson
  • Laboratory Corporation of America Holdings
  • Life Technologies Corp.
  • Merck KGaA
  • Mitsubishi Tanabe Pharma Corp.
  • Myriad Genetics Inc.
  • Novartis AG
  • Novartis AG
  • PerkinElmer Inc.
  • Pfizer Inc.
  • Pfizer Inc.
  • Quest Diagnostics Inc.
  • Sanofi S.A.
  • Sanofi S.A.
  • Siemens Healthcare
  • Sigma-Aldrich Corp.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • Transgenomic Inc.

For more information visit http://www.researchandmarkets.com/research/5pbz3g/future_prospects

Media Contact: Laura Wood, +353-1-481-1716, [email protected]

SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.